Diana Girnita, MD, PhD, founder and CEO of Rheumatologist OnCall, has a thriving YouTube channel with nearly 100K subscribers and over 500 videos to date. She...
Our ophthalmology month in review for June 2024 focuses on updates to the pipeline, a look at the impact of vision problems on public health in...
Credit: Unsplash/Bady Abbas A recent investigation in JAMA Ophthalmology evaluated the frequency of topical antibiotic treatment and its association with healthcare use among children and adolescents...
Jennifer Goldman, RPh, PharmDCredit: Massachusetts College of Pharmacy Since the turn of the century, diabetes management has seen, and is still in the midst of, dramatic...
When the 2024 Wimbledon Championships commence on July 1, all eyes will not only be on the court but also in the stands, where the players’...
Richard Pratley, MDCredit: Advent Health Diabetes Institute Exactly 1 month after its original presentation at the 61st European Renal Association Congress, the FLOW trial and semaglutide...
Credit: Adobe Stock/eddows Treatment with romosozumab or denosumab among patients with either primary osteoporosis or rheumatoid arthritis (RA) complicated with osteoporosis (RA-OP) demonstrated clinical efficacy over...
On the opening day of the 84th American Diabetes Association Scientific Sessions, the ADA ushered in a new era for their organization with the announcement of...
Despite medical cannabis in the US dating back more than 3 decades, the legalization movement in the last decade means millions and millions of US adults...
Todd Hagobian, PhD Credit: Cal Poly Findings from a recent study suggest limiting exposure to bisphenol A (BPA) may help reduce the risk of type 2...
We caught up with Nick Lester, the team manager for Muc-Off Young Guns, who also happens to be an expert in data acquisition. In recent years,...
David Preiss, MBChB, PhD Credit: University of Oxford Fenofibrate, a common cholesterol-lowering drug, significantly reduced the progression of vision loss in patients with diabetic retinopathy (DR),...